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Acute and chronic effects of a light-activated FGF receptor
in keratinocytes in vitro and in mice
Theresa Rauschendorfer1 , Selina Gurri1, Irina Heggli1, Luigi Maddaluno1 , Michael Meyer1, Álvaro Inglés-Prieto2 ,
Harald Janovjak2,3,4 , Sabine Werner1
FGFs and their high-affinity receptors (FGFRs) play key roles in
development, tissue repair, and disease. Because FGFRs bind
overlapping sets of ligands, their individual functions cannot be
determined using ligand stimulation. Here, we generated a light-
activated FGFR2 variant (OptoR2) to selectively activate signaling
by the major FGFR in keratinocytes. Illumination of OptoR2-
expressing HEK 293T cells activated FGFR signaling with re-
markable temporal precision and promoted cell migration and
proliferation. In murine and human keratinocytes, OptoR2 acti-
vation rapidly induced the classical FGFR signaling pathways and
expression of FGF target genes. Surprisingly, multi-level counter-
regulation occurred in keratinocytes in vitro and in transgenic
mice in vivo, including OptoR2 down-regulation and loss of re-
sponsiveness to light activation. These results demonstrate un-
expected cell type–specific limitations of optogenetic FGFRs in
long-term in vitro and in vivo settings and highlight the complex
consequences of transferring optogenetic cell signaling tools into
their relevant cellular contexts.
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Introduction
FGFs comprise a group of 22 structurally related proteins in
mammals, which play key roles in development, repair, and disease
(Beenken & Mohammadi, 2009; Ornitz & Itoh, 2015). Most of them
signal through four tyrosine kinase receptors (FGFR1-4). The bio-
logical output of FGF signaling depends on the type of FGF and FGFR,
on the cell type and on the presence of heparan sulphate pro-
teoglycans on the cell surface, which are required for FGF receptor
binding and activation (Beenken &Mohammadi, 2009; Ornitz & Itoh,
2015). For example, FGF7 and FGF10 both activate the “b” splice
variant of FGFR2 (FGFR2b), but FGF7 induced receptor degradation
and cell proliferation in HeLa cells, whereas FGF10 treatment in-
duced receptor recycling and cell migration (Francavilla et al, 2013).
Little is known on how different cellular responses are activated by
stimulation of the same receptor with different FGFs or by stim-
ulation of different receptors with the same ligand. In addition,
there are unsolved issues regarding possible unique or synergistic
effects of different types of FGFRs. This is particularly relevant for
cells, which express multiple FGF receptors, such as keratinocytes.
These cells express FGFR2 and FGFR3 and very low levels of FGFR1,
with FGFR2 being the most relevant receptor for epidermal function
(Yang et al, 2010; Meyer et al, 2012). Their activation is of crucial
importance for the maintenance of epidermal barrier function and
wound healing, and mice lacking FGFR1 and FGFR2 in keratinocytes
develop a phenotype resembling the inflammatory skin disease
Atopic Dermatitis (Yang et al, 2010) and show a severe defect in
wound re-epithelialization (Meyer et al, 2012).
To test the contribution of an individual FGFR to a cellular
function, it should be selectively activated in a precise manner
both in space and time, which is not possible using the ligands.
A promising alternative is optogenetics, where photoactivatable
protein domains are used to tightly control andmanipulate cellular
signaling networks (Gorostiza & Isacoff, 2008; Airan et al, 2009;
Toettcher et al, 2011; Tischer & Weiner, 2014; Pudasaini et al, 2015;
Rogers & Muller, 2020). FGFRs were among the first optogenetic
tools developed specifically to manipulate cellular signaling. Ini-
tially, two versions of a light-regulated FGFR1 were generated and
characterized. One version takes advantage of aureochrome light-
oxygen-voltage (LOV) domains for receptor homodimerisation, and
illumination of this modified FGFR1 activated the canonical intra-
cellular signaling cascades and induced proliferation, migration
and in vitro capillary formation of endothelial cells (Grusch et al,
2014). The second uses cryptochrome 2 homo-interaction to
induce receptor clustering, and allowed light-induced activation of
downstream signaling pathways, cytoskeletal reorganisation, and
directed cell migration (Kim et al, 2014). Further modifications of
FGFR1 rendered it sensitive to red light (Reichhart et al, 2016;
Leopold et al, 2019, Leopold et al, 2020), induced membrane re-
cruitment of the receptor (Krishnamurthy et al, 2020) or of a photo-
domain (Bugaj et al, 2013), or resulted in receptor inactivation upon
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illumination (Kainrath et al, 2017; Kainrath & Janovjak, 2020).
However, optogenetic FGFR activation was never extended past
FGFR1. Furthermore, light-activated FGFRs and light-activated re-
ceptors or signaling proteins in general have not been deployed in
vivo in transgenic rodents, which would allow precise timing of
FGFR activation in a tissue-specific manner if the transgene is
driven by specific promoters. Therefore, important open questions
exist in the context of transferring this and also other optogenetic
cell signaling technology to relevant biological contexts: (1) Are
light-activated signaling receptors applicable in transgenic animals
(Zeng & Madisen, 2012; Ting & Feng, 2013)? (2) What are potential
negative consequences and how do these depend on cell type and
strategy? Studies with virally delivered and recombinase-enabled
optogenetic actuators (Nectow & Nestler, 2020) or bacterial cyclic
nucleotide producing enzymes (Jansen et al, 2015; Luyben et al,
2020) or experiments in transgenic invertebrate models (Husson et
al, 2013; Guglielmi et al, 2015; Johnson et al, 2017; Bunnag et al, 2020)
have shown promising results. However, the general feasibility of
non-neuronal optogenetics, which uses this strategy to activate cell
signaling in contexts outside of the nervous system, has not been
demonstrated in transgenic rodents.
Because of the important function of FGFR2 in keratinocytes, we
generated a version of this receptor, which gets activated by blue
light instead of its natural ligand (named OptoR2). OptoR2 robustly
activated FGFR signaling and inducedmigration and proliferation in
human embryonic kidney (HEK) 293T cells and caused FGFR sig-
naling, alterations in gene expression and short-term migration in
keratinocytes. However, down-regulation of the receptor was ob-
served in keratinocytes, suggesting that long-term activation of
OptoR2, even at a low level, is deleterious for these cells. These
results unravel advantages, but also some limitations of opto-
genetics for the analysis of growth factor signaling.
Results
Light induces FGFR2 activation in OptoR2-expressing HEK
293T cells
We established an optogenetic approach to selectively activate
FGFR2 in keratinocytes. For this purpose, an epitope-tagged aur-
eochrome LOV domain was fused C-terminally to the intracellular
part of FGFR2. The extracellular ligand binding domains were re-
moved, and the receptor was anchored to the cell membrane using
a myristoylation signal (Fig 1A). Consequently, OptoR2 is not re-
sponsive to its natural ligands, but only to blue light.
HEK 293T cells, which stably and constitutively express OptoR2,
responded to 15-min exposure to blue light with phosphorylation/
activation of ERK1/2, which was comparable to the level achieved
with EGF (Fig 1B). By contrast, vector-transfected control (ctrl) and
OptoR2-expressing HEK 293T cells only responded weakly to FGF7
and FGF10, the ligands of the FGFR2b splice variant that is highly
expressed in keratinocytes. This is consistent with the weak ex-
pression of FGFR2 in HEK 293T cells compared with immortalized
human keratinocytes (HaCaT cells) (Fig S1A). As expected, illumi-
nation of ctrl cells had no effect on ERK1/2 activation (Fig 1B).
Immunofluorescence staining confirmed the robust activation of
ERK1/2 (Fig 1C).
Using light-emitting diodes (LEDs), we found that OptoR2 was
activated by blue light (λ ~ 450 nm) and by white LEDs that emitted
light of a continuous spectrum, but not by red light (λ ~ 700 nm) (Fig
1D). This is consistent with the activation characteristics of flavin
mononucleotide, the ubiquitously present light-sensitive co-factor
of LOV domains. A 1-s illumination pulse with blue light was suf-
ficient to induce ERK1/2 phosphorylation, and 30 s of illumination
were required for maximal activation (Fig 1E). Therefore, a re-
markable temporal precision can be achieved with OptoR2.
Activation of OptoR2 also resulted in phosphorylation of the
scaffold protein FGFR substrate (FRS) 2α (Y196 and Y436), whereas
other signaling molecules that are frequently activated by FGFRs,
such as AKT and p38 (Ornitz & Itoh, 2015), were neither activated by
blue light nor by FGFs (Fig S1B). The kinetics of ERK1/2 activation by
OptoR2 was comparable to the activation of FGFR2 by its natural
ligands FGF7 and FGF10, although the extent of activation by light
was much stronger (Fig S1C).
In scratch wounding assays, OptoR2-expressing HEK 293T cells
migrated significantly faster in the light than in the dark, whereas
FGF7 and FGF10 had only a weak or no effect, respectively (Fig 1F).
Their proliferation was also significantly increased when exposed to
blue light for 1 or 24 h, with the longer exposure being more efficient
than the effect achieved with FGFs or FBS (Fig 1G). Of note, minimal
residual (i.e., in the dark) signaling activity was observed (e.g., Figs 1B
and S1B and C), rendering OptoR2 a highly efficient optogenetic tool.
OptoR2 is functional in primary and immortalized murine
keratinocytes, but undergoes down-regulation
We next generated transgenic mice expressing OptoR2 under the
control of the keratin 14 (K14) promoter, which targets expression of
transgenes to basal keratinocytes of the epidermis and outer root
sheath keratinocytes of the hair follicles (Fuchs, 1993). For expression
of the transgene, we used a well-characterized expression cassette
((Munz et al, 1999); Fig 2A). Three transgenicmouse lineswere obtained,
but only primary keratinocytes from one line expressed the transgene
at significant levels (transgenic mouse line 1; Figs 2B and S2A). Kera-
tinocytes, which expressed the transgene, responded to 15 min blue
light as well as to FGF7 treatment with phosphorylation of ERK1/2 (Fig
2B). Nodetectable signaling activity of the receptorwasobserved in the
absence of light. These results demonstrate that a promoter of a gene,
which is endogenously expressed in keratinocytes, can be used to
drive transgene expression. However, we found individual differences
in the OptoR2 expression levels between cells from different pups of
one litter. Furthermore, freshly isolated primary keratinocytes from the
progeny of mouse line 1 (1.5 yr or 3 generations later) no longer
responded in the same experimental setting (Fig 2B). This ismost likely
the consequence of a strong down-regulation of OptoR2, which was
observed both at the mRNA and at the protein level (Fig 2C).
We also examined spontaneously immortalized keratinocytes
obtained from cells of the first generation of mice. Although these
cells showed robust ERK1/2 activation in response to blue light
shortly after immortalization, continuous passaging and cultivation
for 6 mo completely abolished their light response (Fig 2D). Both
illumination and FGF treatment strongly stimulated cell migration
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at the beginning of the cultivation period, but only FGFs induced
migration 6 mo later, whereas light had no effect (Fig 2E). An ad-
ditional OptoR2 cell line also lost the light responsiveness (Fig S2B).
Expression of OptoR2 induces skin tumour formation
We also noticed changes in the adult mice of this colony. In the
early generations, a high percentage of the transgenic mice, in
particular males, developed epithelial skin tumours at light-
exposed sites (back, face) at the age of 6–12 wk (Fig 3A, left up-
per panel), which were highly keratinized and showed strong cell
proliferation (Fig 3A, upper right and lower left panels). This phenotype
prevented us from performing in vivo illumination experiments, and
the mice were euthanized according to animal welfare regulations at
an early stage of tumour development.
Membrane staining for OptoR2 was seen in the tumour cells (Fig
3A, lower right panel), whereas the expression level of OptoR2 in the
normal back skin was below the detection limit. The up-regulation
of OptoR2 in the tumours is consistent with the strong activity of the
K14 promoter in hyperproliferative epithelia (Fuchs, 1993). These
findings suggest that the continuous weak activation of OptoR2,
which occurs under normal housing conditions, results in tumour
formation that is further driven by strong activity of the employed
promoter in keratinocytic tumour tissue.
Correlating with our in vitro findings, the tumour incidence
strongly declined in the following generations in mice of both sexes
Figure 1. OptoR2 is functional in HEK 293T cells.
(A) Schematic representation of endogenous FGFR2b
and OptoR2. AB, acid box; HSPG, heparan sulphate
proteoglycan (HSPG); HA, hemagglutinin epitope; Ig,
immunoglobulin-like domain; LOV, light-oxygen-
voltage domain; Myr, myristoylation signal; TK, tyrosine
kinase domains; TM, transmembrane domain.
(B, C) OptoR2 HEK 293T cells and vector-transduced
control cells (ctrl) were serum-starved for 16 h.
Subsequently, they were left untreated (black bar), or
exposed 15 min to blue light (blue bar), or FGF7,
FGF10, or EGF (10 ng/ml). (B)Western blot for phospho-
ERK1/2 (p-ERK T202/Y204), total ERK1/2, HA (OptoR2),
and GAPDH (loading control).
(C) Immunofluorescence staining for p-ERK1/2 (green).
Nuclei were counterstained with Hoechst 33342 (blue).
Note that the single channels are shown in black and
white; colours are only shown in the merge. Scale bar:
250 μm. (D, E) OptoR2 HEK 293T cells were serum-
starved for 16 h and then illuminated for 15 min with
light of different wavelengths (D) or for 1 s to 1 min with
blue light (E). For (E), lysates were prepared 2 min after
the onset of illumination. Western blots for p-ERK,
total ERK1/2, HA (OptoR2), and GAPDH are shown.
(F) OptoR2-transduced HEK 293T cells were cultured in
medium with 0.5% FBS for 16 h, subjected to scratch
wounding, and illuminated with blue light, or treated
with FGF7, FGF10 (10 ng/ml), or 10% FBS. Bar graph shows
percentage of open scratch at 48 h. (G) OptoR2-
transduced HEK 293T cells were serum-starved for 16 h
and then illuminated for either 1 or 24 h or treated with
FGF7, FGF10 (10 ng/ml), or 10% FBS for 24 h. At 24 h
they were analysed by immunofluorescence staining
for Ki67. The percentage of Ki67-positive cells is shown.
Bar graphs showmean ± SEM. (B, D, E) Representative
of four experiments. (C): Representative pictures of two
experiments. (F): n = 9–45 from three experiments.
(G) n = 18–27 from two experiments. *P ≤ 0.05, **P ≤
0.01, ***P ≤ 0.001, ****P ≤ 0.0001 (Mann–Whitney U test).
Source data are available for this figure.
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(Fig 3B). This supports the hypothesis that continuous OptoR2
expression/activation induces counter-regulatory mechanisms both
in vitro and in vivo.
OptoR2 activation by light mimics signaling by endogenous FGFR2
in human keratinocytes
To avoid the counter-regulation in keratinocytes, we generated
HaCaT cells expressing OptoR2 under the control of a doxycycline
(Dox)-inducible promoter using a lentiviral transduction system
(Fig S3A). These cells responded to 15 min blue light illumination or
exposure to FGF7 or FGF10 with phosphorylation of ERK1/2 (Fig 4A),
consistent with the presence of OptoR2 at the plasma membrane
(Fig 4B).
The kinetics of ERK1/2 activation by light was comparable to the
activation of endogenous FGFR2b by FGF7 and FGF10: ERK1/2 was
phosphorylated already after 5 min of illumination or FGF treat-
ment, followed by a continuous decrease within 2 h (Fig 4C). This
correlated with a rapid (auto)phosphorylation of OptoR2 (Fig 4C).
The sensitivity of the pFGFR2 antibody was not sufficient to detect
the endogenous pFGFR2 in total keratinocyte lysates (data not
shown). FRS2α as well as other downstream effectors were also
Figure 2. OptoR2 expression is functional in murine
keratinocytes, but down-regulated over time.
(A) Construct used for the generation of the transgenic
mice. Functional elements include a human keratin 14
(K14) promoter, a rabbit β-globin intron, the OptoR2
cDNA and the human growth hormone poly A.
(B, C) Primary keratinocytes from one newborn ctrl and
two OptoR2 mice (transgenic mouse line 1) from the
direct offspring of the founder mice or from progeny 1.5
yr (3 generations) later were serum-starved for 24 h and
then left untreated or exposed to blue light or FGF7
or FGF10 (10 ng/ml) for 15 min. (B) Western blot for p-
ERK1/2 (T202/Y204), ERK1/2, HA (OptoR2), and GAPDH.
Note that different exposure times were used for the
HA blots in the left and right panels. (C) Different
batches of untreated primary keratinocytes were
analysed by qRT-PCR for OptoR2 relative to Rps29
and by Western blot for HA (OptoR2) and GAPDH.
(D) Immortalized keratinocytes from K14-OptoR2 mice
and a wild-type littermate (ctrl) were serum-starved
for 24 h and exposed to blue light or FGF7 or FGF10 (10
ng/ml) for 15 min, both at the beginning of the
cultivation period (t = 0) and after extended
cultivation and passaging (t = 6 mo). Western blots for
p-ERK1/2, total ERK1/2, HA (OptoR2), and GAPDH are
shown. (E) Confluent and serum-starved
immortalized keratinocytes were subjected to scratch
wounding and exposed to blue light or FGF7, FGF10 (10
ng/ml), or full keratinocyte growth medium. The
percentage of open scratch at 24 or 48 h is shown in the
bar graphs. Bar graphs show mean ± SEM.
(B) Representative of four experiments. t = 0: n = 4
mice per genotype. t = 1.5 yr: n = 12–18 mice per
genotype. (C) Ctrl littermate expression level was set to
one. One experiment, n = 2–3 mice per genotype.
(D) Representative of two experiments with three cell
lines. (E) t = 0: n = 24 from two experiments. t = 6
mo: n = 20 from three experiments. **** ≤ 0.0001
(Mann-Whitney U-test).
Source data are available for this figure.
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phosphorylated upon illumination of OptoR2-expressing cells or
treatment with FGFs (Fig 4D). We observed no obvious activation of
signaling in the dark in this cell line (Fig 4).
In addition, we tested the construct in primary human fibro-
blasts, which predominantly express FGFR1 (our unpublished RNA
sequencing data). In this cell type, all tested signaling effectors
were phosphorylated upon illumination of OptoR2 or treatment
with FGF2, whereas FGF1, which weakly activates all FGFRs, had only
a minor effect (Fig S3B). This result demonstrates the suitability of
OptoR2 to activate FGFR2 signaling in various cell types.
Illumination of OptoR2-expressing keratinocytes activates FGF
target gene expression and induces migration
Illumination of the OptoR2-expressing HaCaT cells also activated
the expression of known FGFR target genes in keratinocytes,
including dual-specific phosphatase (DUSP) 6, heparin-binding
EGF-like growth factor (HBEGF), and vascular endothelial growth
factor (VEGF) (Frank et al, 1995; Li et al, 2007; Maddaluno et al, 2020).
Their mRNA levels significantly increased after 6 h of stimulation
with FGF7, FGF10, or continuous illumination with blue light (Fig 5A).
Remarkably, dim light (~30 μW/cm2) was sufficient for OptoR2
activation. This light intensity is lower than the intensity required to
activate many other optogenetic tools, for example, mW/cm2 in the
case of engineered ion-conducting opsins (Zeng & Madisen, 2012;
Ting & Feng, 2013), demonstrating the high sensitivity of OptoR2.
Further reduced light doses through intermittent light pulsing with
“1 min on/15 min off” (1/15) or “1 min on/60 min off” (1/60) cycles,
which were introduced to prevent possible negative feedback
mechanisms of receptor down-regulation over extended illumi-
nation periods, were not sufficient to influence the expression of
these genes.
The migratory capacity of HaCaT cells in the scratch wounding
assay was generally rather weak, even in response to FGF7 or FGF10.
Nevertheless, there was amild increase inmigration upon exposure
to continuous or 1/60 intermittent light (Figs 5B and S4A). The rather
weak effect of light might again be a consequence of receptor
down-regulation. Indeed, after 3 h of continuous illumination,
OptoR2 protein levels were slightly reduced and after 24 h, OptoR2
was almost undetectable. OptoR2 mRNA also declined with similar
kinetics, and this correlated with a reduction in DUSP6 mRNA levels
after the initial strong increase, whereas expression of house-
keeping genes was not affected (Figs 5C and S4B and C).
Discussion
We established an optogenetic strategy, which allows induction of
FGFR signaling and downstream behavioural responses with re-
markable temporal precision in HEK 293T cells. Activation of major
FGFR signaling pathways and induction of FGF target gene ex-
pression was also achieved in keratinocytes and fibroblasts,
demonstrating that OptoR2 is highly suitable to study the early
responses to FGFR activation with robust function and minimal
residual activity in its natural cellular context. This finding confirms
previous data, which showed that expression of endogenous FGFR1
does not affect the activity of an OptoR1 protein that was con-
structed in the same way as OptoR2 (Grusch et al, 2014). In the
future, it will be interesting to express OptoR2 together with OptoR1
and other light-activatable receptors to study individual, over-
lapping, or synergistic activities of different FGFRs or other receptor
tyrosine kinases and to identify signaling molecules and target
genes, which are activated by individual receptors.
In spite of these promising results, rapid down-regulation of OptoR2
occurred in murine and human keratinocytes, which was independent
of the promoter used to drive transgene expression. These data
suggest that mild, but chronic FGFR signaling negatively affects ker-
atinocyte viability or plating efficiency. This would result in se-
lection of cells, which have down-regulated the receptor. We did
not observe significant cell death of the OptoR2-expressing
keratinocytes at any given time point, but even apoptosis of a
small percentage of cells may result in progressive overgrowth by
Figure 3. OptoR2 expression in keratinocytes of transgenic mice induces skin
tumour formation, which declines over time.
(A) Left upper panel: Adult K14-OptoR2 mouse with a skin tumour. Other panels:
Representative photomicrographs from skin tumour sections; hematoxylin &
eosin staining (top right), Ki67 immunohistochemistry and counterstaining with
hematoxylin (bottom left), or immunofluorescence staining for HA (OptoR2;
green) and the endothelial cell marker CD31 (red) (bottom right). Nuclei were
counterstained with Hoechst 33342 (blue). Scale bar: 100 μm. Representative
pictures of n = 11 mice are shown. (B) Tumour incidence in adult K14-OptoR2 mice
of both sexes during the first and second year after generation of the mouse line.
Number of mice with tumours and of total mice is indicated in the graph.
Source data are available for this figure.
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keratinocytes that have down-regulated the receptor. It is also
possible that the differentiation of OptoR2-expressing keratinocytes
is enhanced. This hypothesis is supported by the delayed kerati-
nocyte differentiation in mice expressing a dominant-negative FGFR
in suprabasal keratinocytes (Werner et al, 1993) and the induction
of early and late differentiation in HaCaT keratinocytes by over-
expression of FGFR2b and stimulation with FGF7 (Belleudi et al, 2011;
Rosato et al, 2018). Although we did not observe a strong effect of
OptoR2 expression on keratinocyte differentiation markers in pilot
in vitro experiments, a continuous mild effect on differentiation
may lead to the loss of some differentiated cells upon passaging.
In the future, it will be interesting to further study the mecha-
nisms underlying the loss of OptoR2 expression or responsiveness
in keratinocytes. Epigenetic mechanisms may be involved, as
previously shown for transgene silencing in different mouse lines
(Calero-Nieto et al, 2010; Blewitt & Whitelaw, 2013; Gödecke et al,
2017). In addition to loss of transgene expression, negative feedback
regulationmay occur in response to OptoR2 activation, for example,
via activation of endogenous signaling inhibitors (Ornitz & Itoh,
2015). However, this does not explain the rapid loss of the receptor
upon continuous illumination of OptoR2-expressing HaCaT kera-
tinocytes. Therefore, active receptor down-regulation is likely to
occur as previously suggested for wound keratinocytes, where high
levels of FGF7 are present (Marchese et al, 1995). At the protein level,
this is achieved by receptor ubiquitination and subsequent in-
ternalization, which is frequently followed by proteasomal
degradation (Francavilla et al, 2013; Ornitz & Itoh, 2015). Down-regulation
of FGFR2mRNA by FGFR activation has also been observed in fibroblasts
Figure 4. Activation of inducibly expressed OptoR2 in
human keratinocytes mimics FGFR2 signaling.
HaCaT cells were serum-starved and treated with 50
ng/ml Dox or DMSO (vehicle, -Dox) for 24 h. (A) OptoR2-
and vector-transduced (ctrl) HaCaT cells were then
left untreated, illuminated or treated with FGF7 or
FGF10 (10 ng/ml) for 15 min. Western blots for p-ERK1/2,
total ERK1/2, HA (OptoR2), and GAPDH.
(B) Immunofluorescence staining for HA (OptoR2; red)
and the membrane protein E-cadherin (green),
counterstained with Hoechst 33342 (blue). Single
channels are shown in black and white; colours are
only shown in the merge. Scale bar: 10 μm.
(C, D) OptoR2-HaCaT cells were illuminated with blue
light or treated with FGF7 or FGF10 (10 ng/ml) for 5, 15,
30, 60, or 180 min (C) or for 2, 5, or 10 min (D). Western
blots for OptoR2 (HA), GAPDH, and total and
phosphorylated forms of different signaling molecules
are shown. (A) Representative of six experiments.
(B) Representative confocal pictures of two
experiments. (C) Representative of two experiments.
(D) Representative of six experiments.
Source data are available for this figure.
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and did not involve reduced transcription (Ali et al, 1995). Therefore,
mRNAdecay is amore likelymechanism,whichmayoccur in response to
FGFR kinase activation and/or continuous light exposure. Our newly
developed OptoR2 could be an important tool to address the mecha-
nisms of receptor down-regulation in the future.
There are several possibilities to adjust the optogenetic system to
optimize its function. First, the light conditions could be furthermodified
bypulsed illumination (Hennemannet al, 2018) or theexpression level of
OptoR2 could be lowered by using a different promoter. In addition, the
lifetime of LOV-domain photoreceptors is highly tunable (Zoltowski et al,
2009), andalthough in general the aim is to increase the sensitivity of the
receptors, in this case its activation in the light should rather be
dampened. Another approach is to apply an optogenetic system that
uses light of otherwavelengths, for example, far red light (Reichhart et al,
2016). For transgenic mice that express optogenetic receptors in
light-exposed tissues, cages with colour-filtering properties should
be used because reduction of ambient light in animal colonies is
not compatible with animal welfare regulations in many countries.
Taken together, our study identified major strengths, but also limita-
tions of optogenetic FGFR activation, which are likely dependent on the
cell type and the genetic strategy. This should be taken into consideration
in future in vitro and in vivo studies. Further optimization of optogenetic
approaches for the activation of growth factor signaling will be important
and should be tailored to the type of receptor and the target cell.
Materials and Methods
Recombinant proteins, antibodies, and primers
The following recombinant proteins were used: Murine EGF (E4127;
Sigma-Aldrich), human FGF1 (100-17; PeproTech), human FGF2 (100-
18; PeproTech), human FGF7 (100-19; PeproTech), and human FGF10
(100-26; PeproTech). Standard chemicals were from Sigma-Aldrich
or Merck.
Generation of OptoR2
The transgene encoding OptoR2 was generated by restriction digest
and ligation. For this purpose, the intracellular domain (ICD) of
human FGFR2 was tagged N-terminally with a myristoylation do-
main for membrane anchorage and fused with the aureochrome
LOV domain from Vaucheria frigida, tagged at the C terminus with a
hemagglutinin (HA) epitope. In the used region, mouse FGFR2 ex-
hibits 92% sequence identity to human FGFR2, and the murine and
human receptors can fully substitute each other’s function (Ornitz
& Itoh, 2015).
Mice
The transgenic mouse line was generated by inserting the OptoR2-
transgene under the control of the K14-promoter (Fig 2A) into C57BL/6
mouse oocytes by microinjection. After implanting the embryos into
foster mice and delivery, their offspring was genotyped. Transgenic
animals were used to establish three independent mouse lines, of
which two exhibited undetectable transgene expression levels (Fig
S2A). Mice were kept in C57BL/6 background under specific pathogen-
free conditions according to federal guidelines with food and water ad
libitum and a 12 h light–dark cycle. All mouse experiments were ap-
proved by the local veterinary authorities of Zurich, Switzerland
(Kantonales Veterinäramt der Stadt Zürich, Switzerland). Mice with a
single skin tumour that reached 1 cm diameter, with more than one
tumour of at least 0.5-mm diameter or with tumours at a burdening
body site were euthanized according to animal welfare regulations.
Figure 5. Activation of OptoR2 in human
keratinocytes induces expression of FGF target
genes and promotes cell migration.
OptoR2-transduced HaCaT cells were serum-starved
and treated with 50 ng/ml Dox or DMSO for 24 h.
(A) Cells were left untreated, illuminatedwith blue light
(“1 min on/15 min off” [1/15] cycles, “1 min on/60 min
off” [1/60] cycles, continuous illumination) or treated
with FGF7 or FGF10 (10 ng/ml) for 6 h. RNA samples
were analysed by qRT-PCR for DUSP6, HBEGF, and VEGF
relative to RPL27. (B) Cells were subjected to scratch
wounding and illuminated using three different
illumination schemes or incubated with 10 ng/ml FGF7
or FGF10. The percentage area of open scratch at 72 h
is shown in the bar graph. (C) Cells were illuminated for
15 min, 3 h or 24 h using three different illumination
schemes and analysed by Western blot for HA
(OptoR2) and GAPDH. Bar graphs show mean ± SEM.
(A) “dark − Dox” expression level was set to one. n = 4–7
from two to five experiments. (B) n = 36 from two
experiments. (C) Representative of three experiments.
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, **** ≤ 0.0001
(Mann–Whitney U test).
Source data are available for this figure.
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For genotyping, skin obtained upon ear clipping was digested with
proteinase K (A3830; AppliChem) and then used for the genotyping
PCR. The genotyping mix contains 0.5 μl tissue lysate, 8 μl KAPA2G
genotyping mix (KK5620; Roche), 6 μl ddH2O, and 1 μl primer mix
(10 μM). The PCR reaction was performed as described in the table,
and the samples were analysed in a 2% agarose gel in SBA buffer
containing 20 mM NaOH and 80.8 mM boric acid in water.
Establishment of murine primary keratinocyte cultures
Primary keratinocytes were obtained from 3- to 5-d old pups as
described previously (Braun et al, 2002), with fewmodifications. The
pups were euthanized and the whole trunk skin was peeled off. After
scraping off the subcutaneous fat tissue, the skin was incubated with
0.8% (wt/vol) trypsin (27250-018; Thermo Fisher Scientific) in DMEM
(Merck) for 1 h at 37°C. Afterwards, the epidermis was separated from
the dermis and incubated for 30 min at 37°C with 0.025% (wt/vol)
DNase (DN25; Sigma-Aldrich) in DMEM + 10% (vol/vol) FBS (A3160802,
LOT 2166297; Thermo Fisher Scientific). The cell pellet was
resuspended in keratinocyte growth medium (Braun et al, 2002) and
the cells seeded in cell culture dishes pre-coated with collagen IV
(C7521; Sigma-Aldrich) in PBS (2.5 μg/cm2). They were cultivated for up
to 1 wk.
Cell culture
Human embryonic kidney T (HEK 293T) cells (Sigma-Aldrich),
low-passage human immortalized keratinocytes (HaCaT cells)
(Boukamp et al, 1988) (kindly provided by Prof. P. Boukamp, Leibniz
Institute for Environmental and Medical Research), primary and spon-
taneously immortalized murine keratinocytes (established in this study),
and human primary foreskin fibroblasts (kindly provided by Dr. Hans-
Dietmar Beer, University of Zurich, Switzerland) were used. They were
cultivated in DMEM + 10% FBS (HEK 293T, HaCaT, and human primary
fibroblasts) or keratinocyte growth medium as described previously
(Braun et al, 2002) (primary and immortalized murine keratinocytes) and
List of secondary antibodies.
Antigen species Coupled with Dilution Application Catalogue no. Manufacturer
Mouse Cy2 1:200 Immunofluorescence 115-225-003 Jackson ImmunoResearch
Mouse HRP 1:5,000 Western blot W4021 Promega
Rabbit Biotin 1:500 Immunohistochemistry 111-065-003 Jackson ImmunoResearch
Rabbit Cy2 1:200 Immunofluorescence 111-225-144 Jackson ImmunoResearch
Rabbit Cy3 1:200 Immunofluorescence 111-165-003 Jackson ImmunoResearch
Rabbit HRP 1:5,000 Western blot W4011 Promega
Rat Cy3 1:200 Immunofluorescence 712-165-153 Jackson ImmunoResearch
List of primary antibodies.
Antigen Host Dilution Application Catalogue no. Manufacturer
AKT Rabbit 1:1,000 Western blot 9272 Cell Signaling Technologies
AKT (phospho T308) Rabbit 1:1,000 Western blot 9275 Cell Signaling Technologies
AKT (phospho S473) Rabbit 1:1,000 Western blot 3787 Cell Signaling Technologies
CD31 Rat 1:100 Immunofluorescence 553370 BD Biosciences
E-Cadherin Mouse 1:100 Immunofluorescence 610181 BD Biosciences
ERK Rabbit 1:1,000 Western Blot 9102 Cell Signaling Technologies
ERK (phospho T202/Y204) Rabbit 1:100 Immunofluorescence 9101 Cell Signaling Technologies
1:1,000 Western blot
FGFR2 (phospho Y769) Rabbit 1:1,000 Western blot PA5-105880 Thermo Fisher Scientific
FRS2α (phospho Y196) rabbit 1:1.000 Western blot 3864 Cell Signaling Technologies
FRS2α (phospho Y436) Rabbit 1:1,000 Western blot 3861 Cell Signaling Technologies
GAPDH Mouse 1:5,000 Western blot 5G4cc HyTest
HA (OptoR2) Rabbit 1:100 Immunofluorescence 3724 Cell Signaling Technologies
1:1,000 Western blot
Ki67 Rabbit 1:500 Immunohistochemistry, Immunofluorescence ab16667 Abcam
p38 Rabbit 1:1,000 Western blot 9212 Cell Signaling Technologies
p38 (phospho T180/Y182) Rabbit 1:1,000 Western blot 9211 Cell Signaling Technologies
PLCγ (phospho S1248) Rabbit 1:1,000 Western blot 4510 Cell Signaling Technologies
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passaged twice weekly. All cell lines were routinely screened for myco-
plasma and found negative.
For the generation of stable cell lines, lentivirus particles were
generated in HEK 293T cells. Cells were transiently transfected with a
pcDNA-based plasmid (V79020; Thermo Fisher Scientific) or a pInducer
plasmid (Addgene; no. 44012) harbouring theOptoR2 transgeneor empty
vector as a control, together with the packaging plasmids psPAX2
(Addgene no. 12260) and pCMV-VSV-G (Addgene no. 8454) using Lip-
ofectamine 2000 Transfection reagent (11668030; Thermo Fisher Sci-
entific). After virus production for 48 h, the supernatant was collected,
cleared by filtration through a 0.45-μm filter and stored at −80°C. Target
cells were transduced by incubating them for 48 h with the lentivirus-
containing supernatant diluted 1:10 in DMEM + 10% FBS and selected
with 1.5 μg/ml puromycin (P8833; Sigma-Aldrich) (HEK 293T with pcDNA
plasmid) or 1 mg/ml G418 (11811031; Thermo Fisher Scientific) (HaCaT
cells or primary human fibroblasts with pInducer plasmid).
Starvation and illumination
HEK 293T cells, primary human fibroblasts, and HaCaT cells were
starved by washing twice with PBS and changing the medium to
DMEM without FBS. For the primary fibroblasts or HaCaT cells har-
bouring the doxycycline (Dox)-inducible construct, 50 ng/ml Dox
(D1822; Sigma-Aldrich) or the same amount of DMSO (1.02952; Merck)
were added. Murine primary and immortalized keratinocytes were
washed twice with PBS, and their medium was changed to defined
keratinocyte serum-freemedium (10744019; Thermo Fisher Scientific)
without supplements, but with penicillin/streptomycin (P0781;
Merck) and 4.2 pg/ml cholera toxin (C8052; Sigma-Aldrich). The
cells were cultivated under starvation conditions for 16 h (HEK
293T), 24 h (keratinocytes), or 48 h (fibroblasts), respectively.
Afterwards, they were treated with 10 ng/ml FGF7, FGF10, FGF1,
FGF2, or EGF or illuminated with blue light for different time periods.
For short-term continuous illumination (up to 3 h), cell plates were
put underneath a layer of LEDs (5119661; Light & More), while for long-
term illumination, a light chamber for three six-well plates (Greiner) with
one LED for each well was custom-built using an Arduino UNO board
(Arduino). The plates were illuminated using “1 min on/15 min off” or “1
min on/60 min off” cycles or using continuous illumination. The re-
spective dark control cells were covered and kept in the same in-
cubator. Light intensities were measured with a Powermeter (LP1;
Sanwa) and were around 27 and 0.2 μW/cm2 in the light and in the
dark, respectively.
PCR protocol for genotyping.
Cycles Time Temperature
1× 5 min 95°C
33× 35 s 95°C
35 s 60°C
50 s 72°C




1× 10 min 95°C
50× 10 s 95°C
20 s 60°C
20 s 72°C
1× 5 s 95°C
1× 1 min 65°C
1× Slow heat 95°C
Store at 40°C
List of PCR primers.
Gene Sequence Application
DUSP6 (human)
59-GTT CTA CCT GGA AGG TGG CT-39
qRT-PCR
59-AGT CCG TTG CAC TAT TGG GG-39
FGFR2 (human)
59-AGC TGG GGT CGT TTC ATC TG-39
qRT-PCR
59-TTG GTT GGT GGC TCT TCT GG-39
HBEGF (human)
59-TTA GTC ATG CCC AAC TTC ACT TT-39
qRT-PCR
59-ATC GTG GGG CTT CTC ATG TTT-39
OptoR2
59-TGA CCA GCA GCT TGG CAT AA-39
Genotyping PCR
59-GCT CTG CAA ATG GCA CAA CA-39
59-GCT CTG CAA ATG GCA CAA CA-39
qRT-PCR
59-TGA CCA GCA GCT TGG CAT AA-39
RPL27 (human)
59-TCA CCT AAT GCC CAC AAG GTA-39
qRT-PCR
59-CCA CTT GTT CTT GCC TGT CTT-39
Rps29 (mouse)
59-GGT CAC CAG CAG CTC TAC TG-39
qRT-PCR
59-GTC CAA CTT AAT GAA GCC TAT GTC C-39
VEGF (human) Hs_VEGFA_6_SG, QuantiTect Primer Assay (QT01682072) qRT-PCR
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Scratch assay
Cells were cultivated on dishes pre-coated with collagen IV in PBS (2.5
μg/cm2) until they reached full confluency, starved as described
before and treated for 2 h with 2 μg/ml mitomycin C (M4287; Sigma-
Aldrich) to block proliferation. Afterwards, a scratchwas inducedwith a
pipet tip and the cells were washed with PBS before starvation or
treatment media were added. Pictures were taken at the same spot




RNA isolation and qRT-PCR
Cells were washed with PBS before extracting their RNA with the
Mini Total RNA Kit (IB47300; IBI Scientific) according to the man-
ufacturer’s instructions. 1 μg RNA was used for reverse transcription
in a reaction volume of 20 μl with the iScript cDNA synthesis kit
(1708890; Bio-Rad). The product was diluted 1:10 in water, and 5 μl
cDNA were mixed with 5.5 μl LightCycler SYBR green (04887352001;
Roche) and 0.5 μl primer mix (10 μM). The qPCR reaction was
performed according to the program specified in the table, and
data were analysed using the double δ cycle threshold (CT) method.
Preparation of protein lysates and Western blot
Cells were washed with PBS, lysed in lysis buffer containing 240 mM
Tris–HCl pH 6.8, 280 mM SDS, and 40% (vol/vol) glycerol, and heated
to 95°C. After heating the samples for 10 min at 95°C and short
centrifugation, their protein concentration was determined using
the BCA Protein assay kit (23225; Thermo Fisher Scientific) and a
GloMax Microplate Reader (Promega). Afterwards, the samples were
diluted to 1 μg/μl using lysis buffer with a final concentration of 10
mM DTT and bromophenol blue.
Samples of 20 μg protein were separated by SDS–PAGE and
transferred to Protran nitrocellulose membranes (10600001; GE
Healthcare). For probing with phospho-antibodies, membranes
were blocked for 1 h with 5% (wt/vol) BSA (P06-1391100; PAN Bio-
tech) in Tris-buffered saline with Tween 20 (TBS-T) containing 25
mM Tris base, 137 mM NaCl, 2.7 mM KCl, and 0.1% (vol/vol) Tween 20,
pH adjusted to 8.0, whereas the membranes for incubation with
non-phospho antibodies were blocked for 1 h with 5% (wt/vol) skim
milk powder (150141000000; Rapilait) in TBS-T. They were then
incubated with the primary antibody diluted in 5% (wt/vol) BSA in
TBS-T overnight at 4°C, washed thrice for 5 min with TBS-T, incu-
bated for 1 h with the secondary antibody diluted in 5% (wt/vol)
skimmilk powder in TBS-T, and washed thrice for 10 min with TBS-T.
Signals were developed using WesternBright Sirius HRP substrate
(K-12043; Advansta) and the FUSION SOLO 6S chemiluminescence
imaging system (Witec).
Immunofluorescence staining of cells
Cells were cultivated on cover slips, washed with PBS, and fixed for
20 min with 4% (wt/vol) PFA (P6148; Sigma-Aldrich) in PBS. After
washing with PBS, they were permeabilised for 5 min with 0.5% (vol/
vol) Triton X-100 in PBS and washed twice with PBS. Epitopes were
blocked for 1 h with 2% (wt/vol) BSA and 0.05% (vol/vol) Triton X-100
in PBS. Then, the cells were incubated for 1 h with the primary
antibodies diluted in the blocking solution, washed thrice for 5 min
with PBS, and incubated for 1 h with the secondary antibodies and
Hoechst 33342 (1:3,000) diluted in 0.05% (vol/vol) Triton X-100 in
PBS. After washing thrice for 10 min with PBS, they were post-fixed
for 5 min with 1% (wt/vol) PFA in PBS, washed with PBS, and
mounted with ProLong Gold Antifade Mountant (P10144; Thermo
Fisher Scientific). Photomicrographs were taken with an Axiovert
microscope (Carl Zeiss) equipped with a Axiocam 506 mono camera
(Carl Zeiss) at 10× and 20× magnification or with a confocal mi-
croscope (Leica SP8 from Leica) at 63× magnification.
H&E staining of tissue sections
Samples from normal skin or skin tumours were fixed with 4% (wt/
vol) PFA in PBS overnight at 4°C and then gradually dehydrated using
an increasing ethanol gradient before embedding in paraffin
(39601006; Leica Biosystems). Sections (7 μm) were dewaxed and
rehydrated with a decreasing ethanol gradient, before staining them
with hematoxylin and eosin (H&E) according to the program spec-
ified in the table.
Immunofluorescence and immunohistochemistry staining of
tissue sections
PFA-fixed and paraffin-embedded tissue sections were rehydrated and
treated for 40 min with 0.33% (vol/vol) H2O2 in methanol. After washing
the sections twice for 10minwithPBS, antigenswereunmasked in 10mM
sodium citrate pH 6 (71405; Fluka) for 1 h at 95°C. After washing twice for
10 min with PBS, sections were blocked for 1 h with 12% (wt/vol) BSA in
PBS and incubated overnight at 4°C with the primary antibodies diluted
in blocking solution.
Protocol for H&E staining.
Cycles Solution Time
1× Mayer’s Hematoxylin solution 3 min
3× ddH2O 10 s
1× Scott water 30 s
1× ddH2O 10 s
1× 70% (v/v) ethanol/ddH2O 10 s
1× Eosin solution 1 min
2× 80% (v/v) ethanol/ddH2O 10 s
2× 95% (v/v) ethanol/ddH2O 10 s
2× Ethanol 10 s
2× Xylene 10 min
Slides were finally mounted with Eukitt and air-
dried
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For immunofluorescence staining, the sections were then washed
twice for 10 min with PBS, incubated for 1 h with the secondary anti-
bodies diluted in PBS, before washing them thrice for 10 min with PBS.
They were post-fixed for 5 min with 1% (wt/vol) PFA in PBS, washed with
PBS and mounted with ProLong Gold Antifade Mountant. Photomicro-
graphs were taken with an Axiovert microscope (Carl Zeiss) equipped
with an Axiocam 506 mono camera (Carl Zeiss) at 10× magnification.
For immunohistochemistry, sections were washed thrice for 10
min with PBS, incubated for 45 min with the secondary antibody
diluted in PBS, before washing them thrice for 5 min with PBS.
Afterwards, they were incubated with the VECTASTAIN Elite ABC Kit
Peroxidase solution (PK-4000; Maravai Life Sciences), washed again
thrice for 5 min with PBS, before diaminobenzidine Kit solution (SK-
4100; Maravai Life Sciences) was added. They were incubated until
the brown staining was visible. The reaction was stopped by
submersing the slides in tap water. Sections were counterstained
with hematoxylin and mounted with Mowiol (81381; Sigma-Aldrich).
Photomicrographs were taken using a light microscope (Axioskop 2;
Carl Zeiss) equipped with a Axiocam 512 colour camera (Carl Zeiss)
at 2.5×, 10× and 20× magnification.
Statistical analysis
Statistical analysis was performed using the Prism 8 software
(GraphPad Software Inc.). Quantitative data are presented as mean
± SEM. Significance was calculated using Mann–Whitney U test. *P ≤
0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
202101100.
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(2018) Optogenetic control by pulsed illumination. ChemBioChem 19:
1296–1304. doi:10.1002/cbic.201800030
Husson SJ, Gottschalk A, Leifer AM (2013) Optogenetic manipulation of neural
activity in C. elegans: From synapse to circuits and behaviour. Biol Cell
105: 235–250. doi:10.1111/boc.201200069
Jansen V, Alvarez L, Balbach M, Strünker T, Hegemann P, Kaupp UB, Wachten D
(2015) Controlling fertilization and cAMP signaling in sperm by
optogenetics. Elife 4: e05161. doi:10.7554/eLife.05161
Johnson HE, Goyal Y, Pannucci NL, Schüpbach T, Shvartsman SY, Toettcher JE
(2017) The spatiotemporal limits of developmental Erk signaling. Dev
Cell 40: 185–192. doi:10.1016/j.devcel.2016.12.002
Kainrath S, Janovjak H (2020) Design and application of light-regulated
receptor tyrosine kinases.Methods Mol Biol 2173: 233–246. doi:10.1007/
978-1-0716-0755-8_16
Kainrath S, Stadler M, Reichhart E, Distel M, Janovjak H (2017) Green-light-
induced inactivation of receptor signaling using cobalamin-binding
domains. Angew Chem Int Ed Engl 56: 4608–4611. doi:10.1002/
anie.201611998
KimN, Kim JM, Lee M, Kim CY, Chang KY, HeoWD (2014) Spatiotemporal control
of fibroblast growth factor receptor signals by blue light. Chem Biol 21:
903–912. doi:10.1016/j.chembiol.2014.05.013
Krishnamurthy VV, Fu J, Oh TJ, Khamo J, Yang J, Zhang K (2020) A generalizable
optogenetic strategy to regulate receptor tyrosine kinases during
vertebrate embryonic development. J Mol Biol 432: 3149–3158.
doi:10.1016/j.jmb.2020.03.032
Leopold AV, Chernov KG, Shemetov AA, Verkhusha VV (2019)
Neurotrophin receptor tyrosine kinases regulated with near-
infrared light. Nat Commun 10: 1129. doi:10.1038/s41467-019-
08988-3
Leopold AV, Pletnev S, Verkhusha VV (2020) Bacterial phytochrome as a
scaffold for engineering of receptor tyrosine kinases controlled with
near-infrared light. J Mol Biol 432: 3749–3760. doi:10.1016/
j.jmb.2020.04.005
Li C, Scott DA, Hatch E, Tian X, Mansour SL (2007) Dusp6 (Mkp3) is a
negative feedback regulator of FGF-stimulated ERK signaling
during mouse development. Development 134: 167–176.
doi:10.1242/dev.02701
Luyben TT, Rai J, Li H, Georgiou J, Avila A, Zhen M, Collingridge GL, Tominaga T,
Okamoto K (2020) Optogenetic manipulation of postsynaptic cAMP
using a novel transgenic mouse line enables synaptic plasticity and
enhances depolarization following tetanic stimulation in the
hippocampal dentate gyrus. Front Neural Circuits 14: 24. doi:10.3389/
fncir.2020.00024
Maddaluno L, Urwyler C, Rauschendorfer T, Meyer M, Stefanova D, Spörri R,
Wietecha M, Ferrarese L, Stoycheva D, Bender D, et al (2020)
Antagonism of interferon signaling by fibroblast growth factors
promotes viral replication. EMBO Mol Med 12: e11793. doi:10.15252/
emmm.201911793
Marchese C, Chedid M, Dirsch OR, Csaky KG, Santanelli F, Latini C, Larochelle
WJ, Torrisi MR, Aaronson SA (1995) Modulation of keratinocyte growth
factor and its receptor in reepithelializing human skin. J Exp Med 182:
1369–1376. doi:10.1084/jem.182.5.1369
Meyer M, Müller AK, Yang J, Moik D, Ponzio G, Ornitz DM, Grose R, Werner S
(2012) FGF receptors 1 and 2 are key regulators of keratinocyte
migration in vitro and in wounded skin. J Cell Sci 125: 5690–5701.
doi:10.1242/jcs.108167
Munz B, Hübner G, Tretter Y, Alzheimer C, Werner S (1999) A novel role of
activin in inflammation and repair. J Endocrinol. 161: 187–193.
doi:10.1677/joe.0.1610187
Nectow AR, Nestler EJ (2020) Viral tools for neuroscience. Nat Rev Neurosci 21:
669–681. doi:10.1038/s41583-020-00382-z
Ornitz DM, Itoh N (2015) The fibroblast growth factor signaling pathway.Wiley
Interdiscip Rev Dev Biol 4: 215–266. doi:10.1002/wdev.176
Pudasaini A, El-Arab KK, Zoltowski BD (2015) LOV-based optogenetic devices:
Light-driven modules to impart photoregulated control of cellular
signaling. Front Mol Biosci 2: 18. doi:10.3389/fmolb.2015.00018
Reichhart E, Ingles-Prieto A, Tichy AM, Mckenzie C, Janovjak H (2016) A
phytochrome sensory domain permits receptor activation by red
light. Angew Chem Int Ed Engl 55: 6339–6342. doi:10.1002/
anie.201601736
Rogers KW, Müller P (2020) Optogenetic approaches to investigate
spatiotemporal signaling during development. Curr Top Dev Biol 137:
37–77. doi:10.1016/bs.ctdb.2019.11.009
Rosato B, Ranieri D, Nanni M, Torrisi MR, Belleudi F (2018) Role of FGFR2b
expression and signaling in keratinocyte differentiation: Sequential
involvement of PKCδ and PKCα. Cell Death Dis 9: 565. doi:10.1038/
s41419-018-0509-x
Ting JT, Feng G (2013) Development of transgenic animals for optogenetic
manipulation of mammalian nervous system function: Progress and
prospects for behavioral neuroscience. Behav Brain Res 255: 3–18.
doi:10.1016/j.bbr.2013.02.037
Tischer D, Weiner OD (2014) Illuminating cell signalling with
optogenetic tools. Nat Rev Mol Cell Biol 15: 551–558. doi:10.1038/
nrm3837
Toettcher JE, Voigt CA, Weiner OD, Lim WA (2011) The promise of optogenetics
in cell biology: Interrogating molecular circuits in space and time. Nat
Methods 8: 35–38. doi:10.1038/nmeth.f.326
Werner S, Weinberg W, Liao X, Peters KG, Blessing M, Yuspa SH, Weiner RL,
Williams LT (1993) Targeted expression of a dominant-negative FGF
receptor mutant in the epidermis of transgenic mice reveals a role of
FGF in keratinocyte organization and differentiation. EMBO J 12:
2635–2643. doi:10.1002/j.1460-2075.1993.tb05924.x
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